|
Viewpoint
Women's Health
The White House Initiative on Women’s Health Research
Carolyn M. Mazure, PhD
Women's Health
Contraceptive Access in the US Post-Dobbs
Cynthia C. Harper, PhD; Katherine Brown, MD, MAS; Kavita Shah Arora, MD, MBE, MS
Women's Health
Screening Mammography for 40-Year-Old Women—Whose Decision?
Karla Kerlikowske, MD; Laura Esserman, MD, MBA; Jeffrey A. Tice, MD
Cybersecurity Lessons From the Change Healthcare Attack
Hannah T. Neprash, PhD; Christian Dameff, MD, MS; Jeffrey Tully, MD
How to Choose the Best Job for You
Daniel M. Blumenthal, MD, MBA; Mike Jellinek, MD
Inside Story
Health Equity
Language Discordance and Patient Care—Babel
Tamara A. Huson, MD
Original Investigation
Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology: Post Hoc Analysis of the STEP 1, 2, 3, and 5 Trials
Thomas A. Wadden, PhD; Gregory K. Brown, PhD; Christina Egebjerg, PhD; et al.
Editor's Note: Glucagon-Like Peptide-1 Receptor Agonists and Suicidality—Two Important Pieces of Data but an Incomplete Puzzle; Timothy S. Anderson, MD, MAS; Deborah Grady, MD, MPH
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Peter Ueda, MD, PhD; Jonas Söderling, PhD; Viktor Wintzell, PhD; et al.
Editor's Note: Glucagon-Like Peptide-1 Receptor Agonists and Suicidality—Two Important Pieces of Data but an Incomplete Puzzle; Timothy S. Anderson, MD, MAS; Deborah Grady, MD, MPH
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Fasiha Kanwal, MD, MSHS; Jennifer R. Kramer, MPH, PhD; Liang Li, PhD; et al.
Author Interviews Audio: GLP-1 Receptor Agonists and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Health Equity
Individual-Level Exposure to Residential Redlining in 1940 and Mortality Risk
Sebastian Linde, PhD; Leonard E. Egede, MD, MS, FACP
Health Equity
Redlining and Time to Viral Suppression Among Persons With HIV
John R. Bassler, MS; Lauren Ostrenga, MPH; Emily B. Levitan, ScD; et al.
Less Is More
Patient-Directed Education to Promote Deprescribing: A Nonrandomized Clinical Trial
Katie Fitzgerald Jones, PhD, ACHPN; Kelly Stolzmann, MS; Jolie Wormwood, PhD; et al.
Editorial: Educational Brochures for Deprescribing; Timothy S. Anderson, MD, MAS
Less Is More
Deprescribing of Antihypertensive Medications and Cognitive Function in Nursing Home Residents
Bocheng Jing, MS; Xiaojuan Liu, MS; Laura A. Graham, PhD; et al.
Nurse-Supported Self-Directed Cognitive Behavioral Therapy for Insomnia: A Randomized Clinical Trial
Christi S. Ulmer, PhD, DBSM; Corrine I. Voils, PhD; Amy S. Jeffreys, MStat; et al.
Lactated Ringer vs Normal Saline Solution During Sickle Cell Vaso-Occlusive Episodes
Augusta K. Alwang, MD; Anica C. Law, MD, MS; Elizabeth S. Klings, MD; et al.
Reaction Risk to Direct Penicillin Challenges: A Systematic Review and Meta-Analysis
Kimberly G. Blumenthal, MD, MSc; Liam R. Smith, BS; Jushin Teg S. Mann, BS; et al.
Editorial
Less Is More
Educational Brochures for Deprescribing
Timothy S. Anderson, MD, MAS
Invited Commentary
Health Equity
Racial Residential Segregation, Redlining, and Health
Mary T. Bassett, MD, MPH
Charting the Waters of Sickle Cell Disease With Target Trial Emulation
A. Parker Ruhl, MD, MHS; Matthew M. Hsieh, MD; Elizabeth A. Stuart, PhD
Editor's Note
Glucagon-Like Peptide-1 Receptor Agonists and Suicidality—Two Important Pieces of Data but an Incomplete Puzzle
Timothy S. Anderson, MD, MAS; Deborah Grady, MD, MPH
Teachable Moment
Diagnostic Inertia in Identifying Maturity-Onset Diabetes of the Young
Barbara Haberkorn, MD; Grigorios Christidis, MD, MSc, MHBA
Earn CME credit
Research Letter
Less Is More
Direct-to-Consumer Educational Brochures to Promote Gabapentinoid Deprescribing in Older Adults
Marc-Alexandre Gingras, MD, MSc, MEd; Robert Dubé, MDCM, MSc; Jerome Williams, MDCM, BSc; et al.
Editorial: Educational Brochures for Deprescribing; Timothy S. Anderson, MD, MAS
Mapping the Evidence Supporting Digital Therapeutics: A Review
Melissa Amyx, PhD, MPH; Ngan Thi Thuy Phi, MSc; Farzaneh Alebouyeh, MSc; et al.
Health Care Policy and Law
Estimated Savings Under the Medicare High-Value Drug List Model
Christopher L. Cai, MD; Aaron S. Kesselheim, MD, JD, MPH; Benjamin N. Rome, MD, MPH
Audio
GLP-1 Receptor Agonists and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Comment & Response
Cytisinicline For E-Cigarette Cessation
Rongzhong Huang, MD, PhD; Tianyang Hu, MD, PhD
Cytisinicline For E-Cigarette Cessation
Adam Edward Lang, PharmD
Cytisinicline For E-Cigarette Cessation—Reply
Nancy A. Rigotti, MD; Neal L. Benowitz, MD; Cindy Jacobs, PhD, MD
Tick Paralysis—A Rare but Important Tick-Borne Disease
Jonathan A. Edlow, MD
Insights for Using Jinlida in Diabetes Prevention
Xinyue Yang, MD; Zhiqiang Zhang, MD
Insights for Using Jinlida in Diabetes Prevention
Kun Zhao, MD; Xiqiao Xiang, MD; Zhenliang Sun, MD
Insights for Using Jinlida in Diabetes Prevention—Reply
Meixia Shang, PhD; Fengmei Lian, MD; Zhenhua Jia, MD
Correction
Error in Figure 1
JAMA Internal Medicine Masthead
JAMA Internal Medicine
|
